Torben Elm

537 total citations
11 papers, 232 citations indexed

About

Torben Elm is a scholar working on Hematology, Genetics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Torben Elm has authored 11 papers receiving a total of 232 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Hematology, 4 papers in Genetics and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Torben Elm's work include Hemophilia Treatment and Research (7 papers), Platelet Disorders and Treatments (5 papers) and Blood Coagulation and Thrombosis Mechanisms (5 papers). Torben Elm is often cited by papers focused on Hemophilia Treatment and Research (7 papers), Platelet Disorders and Treatments (5 papers) and Blood Coagulation and Thrombosis Mechanisms (5 papers). Torben Elm collaborates with scholars based in Denmark, Sweden and Netherlands. Torben Elm's co-authors include Brit B. Sørensen, Lars C. Petersen, Michael Wilken, Ove Svendsen, Dorte X. Gram, Christian L. Brand, Richard D. Carr, Anker Jón Hansen, Bo Åhrén and Søren E. Bjørn and has published in prestigious journals such as Thrombosis and Haemostasis, Journal of Thrombosis and Haemostasis and European Journal of Endocrinology.

In The Last Decade

Torben Elm

10 papers receiving 225 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Torben Elm Denmark 6 120 34 33 29 27 11 232
John E. Cuffe United Kingdom 8 33 0.3× 278 8.2× 39 1.2× 36 1.2× 34 1.3× 8 410
Ling Xie China 10 11 0.1× 99 2.9× 14 0.4× 33 1.1× 10 0.4× 22 293
Michael Devoy United Kingdom 7 11 0.1× 40 1.2× 13 0.4× 212 7.3× 15 0.6× 9 332
Aurélie Batut France 9 38 0.3× 116 3.4× 10 0.3× 60 2.1× 17 0.6× 15 276
Catharina van Heusden United States 9 10 0.1× 69 2.0× 38 1.2× 23 0.8× 7 0.3× 11 263
Katrin Nitz Germany 5 19 0.2× 83 2.4× 43 1.3× 54 1.9× 9 0.3× 10 298
Shuzhen Sun China 9 23 0.2× 52 1.5× 8 0.2× 35 1.2× 7 0.3× 29 234
Bård Bjørnarå Norway 8 11 0.1× 75 2.2× 5 0.2× 17 0.6× 3 0.1× 8 330
Guoqing Jiao China 7 16 0.1× 72 2.1× 7 0.2× 12 0.4× 7 0.3× 14 199
María López-Menduiña Spain 11 17 0.1× 177 5.2× 55 1.7× 152 5.2× 15 0.6× 13 328

Countries citing papers authored by Torben Elm

Since Specialization
Citations

This map shows the geographic impact of Torben Elm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Torben Elm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Torben Elm more than expected).

Fields of papers citing papers by Torben Elm

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Torben Elm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Torben Elm. The network helps show where Torben Elm may publish in the future.

Co-authorship network of co-authors of Torben Elm

This figure shows the co-authorship network connecting the top 25 collaborators of Torben Elm. A scholar is included among the top collaborators of Torben Elm based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Torben Elm. Torben Elm is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Hvid, Henning, et al.. (2025). From early development to maturity: a phenotypic analysis of the Townes sickle cell disease mice. Biology Open. 14(2). 1 indexed citations
2.
Gandhi, Prafull S., Torben Elm, Gerd Schluckebier, et al.. (2024). A bispecific antibody approach for the potential prophylactic treatment of inherited bleeding disorders. Nature Cardiovascular Research. 3(2). 166–185. 10 indexed citations
3.
Elm, Torben, et al.. (2023). In vivo effect of rFVIII and rFVIIa in hemophilia A rats evaluated by the Tail Vein Transection Bleeding Model. Journal of Thrombosis and Haemostasis. 21(5). 1189–1199. 1 indexed citations
4.
Elm, Torben, et al.. (2021). Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice. Journal of Visualized Experiments. 3 indexed citations
5.
Elm, Torben, et al.. (2021). Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice. Journal of Visualized Experiments.
6.
Elm, Torben, Ditte M. Karpf, H. Pelzer, et al.. (2011). Pharmacokinetics and pharmacodynamics of a new recombinant FVIII (N8) in haemophilia A mice. Haemophilia. 18(1). 139–145. 31 indexed citations
7.
Elm, Torben, Mirella Ezban, Thomas N. Krogh, et al.. (2009). Plasma elimination kinetics for factor VII are independent of its activation to factor VIIa and complex formation with plasma inhibitors. Thrombosis and Haemostasis. 101(5). 818–826. 25 indexed citations
8.
Andersson, Ellen, et al.. (2007). Treatment with anti-factor VIIa in acute pancreatitis in rats: Blocking both coagulation and inflammation?. Scandinavian Journal of Gastroenterology. 42(6). 765–770. 9 indexed citations
9.
Gram, Dorte X., Anker Jón Hansen, Michael Wilken, et al.. (2005). Plasma calcitonin gene-related peptide is increased prior to obesity, and sensory nerve desensitization by capsaicin improves oral glucose tolerance in obese Zucker rats. European Journal of Endocrinology. 153(6). 963–969. 81 indexed citations
10.
Petersen, Lars C., Peder Lisby Nørby, Sven Branner, et al.. (2004). Characterization of recombinant murine factor VIIa and recombinant murine tissue factor: a human–murine species compatibility study. Thrombosis Research. 116(1). 75–85. 67 indexed citations
11.
Elm, Torben, et al.. (1995). Simultaneous determination of lofepramine and desipramine by a high-performance liquid chromatographic method used for therapeutic drug monitoring. Journal of Chromatography B Biomedical Sciences and Applications. 665(2). 355–361. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026